Anticyclic Citrullinated Proteins Rapid Test - India CDSCO Medical Device Registration
Anticyclic Citrullinated Proteins Rapid Test is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2019/000001_969eae3ab7a8a5b81777e6c1b0e153f0_ccf91c32b09ad527a607e9b4a2fcaa59. This device is marketed under the brand name Lumella. The license holder is Diabetomics Medical (P) Ltd, and it is classified as Device Class Class B. The approving authority is Telangana.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.
Brand Name
Lumella
License Holder
Diabetomics Medical (P) LtdDevice Class
Approving Authority
Telangana
Product Information
Anticyclic Citrullinated Proteins (Lumella) test kit is a lateral flow immunoassay intended to be used for as an aid to diagnosis by qualitative detection of IgG antibodies to Citrullinated Proteins in serum from patients suspected of Rheumatoid arthritis.
